Liu, Huiqin; Wang, Ying; He, Qi - In: Health economics review 12 (2022) 1, pp. 1-10
Objective In frst-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC), the ORIENT-11 study demonstrated a signifcant progression-free survival and overall survival for sintilimab plus chemotherapy in comparison with chemotherapy alone. But the...